This page shows the latest Newron Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Newron Pharmaceuticals’ Xadago (safinamide) was approved as an add-on treatment for patients already on levodopa/carbidopa and who experience ‘off’ episodes when those medications don’t work well. ... Newron has divided up the commercial rights
Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in
modulator EVP 0962 (EnVivo Pharmaceuticals); the metal protein-attenuating compound called PBT 2 (Prana Biotechnology); and ELND 005 (Speranza Therapeutics). ... Another agent HF 0220 (Newron Pharmaceuticals), an oral epiandrosterone derivative thought
disease) to Newron Pharmaceuticals, triggered the termination of Biotie Therapeutics' acquisition of Newron. ... immunotherapy in phase III for non-small cell lung cancer. 7. Newron Pharmaceuticals/Biotie Therapeutics.
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Dennis Dionne brings expertise from J&J and Novartis. Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs. ... Stefan Weber, chief executive officer of Newron, said: “We sincerely thanks Anders
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...